International Clinical Trial: Pregabalin for Chronic Pelvic Pain in Women

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07818577) titled 'Pregabalin for Chronic Pelvic Pain in Women' on Sept. 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Investigator, Outcomes Assessor).

Primary Sponsor: Beijing Tiantan Hospital

Condition: Chronic Pelvic Pain Chronic Pelvic Pain Syndrome

Intervention: Drug: Pregabalin

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 1, 2026

Target Sample Size: 308

To know more, visit https://clinicaltrials.gov/study/NCT07818577

Published by HT Digital Content Services with permissio...